A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

NCT00000719 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

96

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Zalcitabine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)